PhaseV
Smarter Decisions. AI Optimized Trials.
Cambridge, United States · $65.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- phasevtrials.com
- Total Funding
- $65.0M
- Last Round
- $50.0M Series AMay 2025
- Rounds
- 3
About
PhaseV is a Boston-based technology company that uses causal machine learning and generative AI, augmented by a large patient-level data lake, to help biopharma sponsors and CROs make faster and more accurate clinical development decisions. Its platform supports adaptive trial design, patient stratification, site selection, and portfolio optimization.
Summary
PhaseV is an Artificial Intelligence company based in Cambridge, United States. It has raised $65.0M in total across 3 rounds, most recently a $50.0M Series A round in May 2025. Investors include Viola Ventures, Exor Ventures and Accel.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...